218 related articles for article (PubMed ID: 20097151)
1. Genetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidate.
Singh B; Cabrera-Mora M; Jiang J; Galinski M; Moreno A
Vaccine; 2010 Mar; 28(14):2580-92. PubMed ID: 20097151
[TBL] [Abstract][Full Text] [Related]
2. Expression of disulphide-bridge-dependent conformational epitopes and immunogenicity of the carboxy-terminal 19 kDa domain of Plasmodium yoelii merozoite surface protein-1 in live attenuated Salmonella vaccine strains.
Somner EA; Ogun SA; Sinha KA; Spencer Valero LM; Lee JJ; Harrison JA; Holder AA; Hormaeche CE; Khan ACM
Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():221-229. PubMed ID: 10206702
[TBL] [Abstract][Full Text] [Related]
3. Protective immune responses elicited by immunization with a chimeric blood-stage malaria vaccine persist but are not boosted by Plasmodium yoelii challenge infection.
Alaro JR; Lynch MM; Burns JM
Vaccine; 2010 Oct; 28(42):6876-84. PubMed ID: 20709001
[TBL] [Abstract][Full Text] [Related]
4. Production, characterisation and immunogenicity of a plant-made Plasmodium antigen--the 19 kDa C-terminal fragment of Plasmodium yoelii merozoite surface protein 1.
Ma C; Wang L; Webster DE; Campbell AE; Coppel RL
Appl Microbiol Biotechnol; 2012 Apr; 94(1):151-61. PubMed ID: 22170105
[TBL] [Abstract][Full Text] [Related]
5. Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii.
Kawabata Y; Udono H; Honma K; Ueda M; Mukae H; Kadota J; Kohno S; Yui K
Infect Immun; 2002 Nov; 70(11):6075-82. PubMed ID: 12379684
[TBL] [Abstract][Full Text] [Related]
6. A hybrid multistage protein vaccine induces protective immunity against murine malaria.
Singh B; Cabrera-Mora M; Jiang J; Moreno A
Infect Immun; 2012 Apr; 80(4):1491-501. PubMed ID: 22252877
[TBL] [Abstract][Full Text] [Related]
7. Identification of T cell epitopes on the 33-kDa fragment of Plasmodium yoelii merozoite surface protein 1 and their antibody-independent protective role in immunity to blood stage malaria.
Wipasa J; Hirunpetcharat C; Mahakunkijcharoen Y; Xu H; Elliott S; Good MF
J Immunol; 2002 Jul; 169(2):944-51. PubMed ID: 12097400
[TBL] [Abstract][Full Text] [Related]
8. A Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria Vaccine.
Fonseca JA; Cabrera-Mora M; Kashentseva EA; Villegas JP; Fernandez A; Van Pelt A; Dmitriev IP; Curiel DT; Moreno A
PLoS One; 2016; 11(4):e0154819. PubMed ID: 27128437
[TBL] [Abstract][Full Text] [Related]
9. Enhanced protection against malaria by a chimeric merozoite surface protein vaccine.
Shi Q; Lynch MM; Romero M; Burns JM
Infect Immun; 2007 Mar; 75(3):1349-58. PubMed ID: 17158895
[TBL] [Abstract][Full Text] [Related]
10. Tricomponent immunopotentiating system as a novel molecular design strategy for malaria vaccine development.
Miyata T; Harakuni T; Tsuboi T; Sattabongkot J; Ikehara A; Tachibana M; Torii M; Matsuzaki G; Arakawa T
Infect Immun; 2011 Oct; 79(10):4260-75. PubMed ID: 21807905
[TBL] [Abstract][Full Text] [Related]
11. Analysis of immunological nonresponsiveness to the 19-kilodalton fragment of merozoite surface Protein 1 of Plasmodium yoelii: rescue by chemical conjugation to diphtheria toxoid (DT) and enhancement of immunogenicity by prior DT vaccination.
Stanisic DI; Martin LB; Liu XQ; Jackson D; Cooper J; Good MF
Infect Immun; 2003 Oct; 71(10):5700-13. PubMed ID: 14500491
[TBL] [Abstract][Full Text] [Related]
12. Definition of T cell epitopes within the 19 kDa carboxylterminal fragment of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) and their role in immunity to malaria.
Tian JH; Good MF; Hirunpetcharat C; Kumar S; Ling IT; Jackson D; Cooper J; Lukszo J; Coligan J; Ahlers J; Saul A; Berzofsky JA; Holder AA; Miller LH; Kaslow DC
Parasite Immunol; 1998 Jun; 20(6):263-78. PubMed ID: 9651928
[TBL] [Abstract][Full Text] [Related]
13. Effect of Plasmodium yoelii exposure on vaccination with the 19-kilodalton carboxyl terminus of merozoite surface protein 1 and vice versa and implications for the application of a human malaria vaccine.
Wipasa J; Xu H; Liu X; Hirunpetcharat C; Stowers A; Good MF
Infect Immun; 2009 Feb; 77(2):817-24. PubMed ID: 19015251
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.
Matsumoto S; Yukitake H; Kanbara H; Yamada T
J Exp Med; 1998 Sep; 188(5):845-54. PubMed ID: 9730886
[TBL] [Abstract][Full Text] [Related]
15. Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19).
Ahlborg N; Ling IT; Holder AA; Riley EM
Infect Immun; 2000 Apr; 68(4):2102-9. PubMed ID: 10722607
[TBL] [Abstract][Full Text] [Related]
16. Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.
Jeamwattanalert P; Mahakunkijcharoen Y; Kittigul L; Mahannop P; Pichyangkul S; Hirunpetcharat C
Clin Vaccine Immunol; 2007 Apr; 14(4):342-7. PubMed ID: 17314232
[TBL] [Abstract][Full Text] [Related]
17. Impact of pre-existing MSP1(42)-allele specific immunity on potency of an erythrocytic Plasmodium falciparum vaccine.
Bergmann-Leitner ES; Duncan EH; Mease RM; Angov E
Malar J; 2012 Sep; 11():315. PubMed ID: 22958482
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
[TBL] [Abstract][Full Text] [Related]
19. Protective immune responses to the 42-kilodalton (kDa) region of Plasmodium yoelii merozoite surface protein 1 are induced by the C-terminal 19-kDa region but not by the adjacent 33-kDa region.
Ahlborg N; Ling IT; Howard W; Holder AA; Riley EM
Infect Immun; 2002 Feb; 70(2):820-5. PubMed ID: 11796616
[TBL] [Abstract][Full Text] [Related]
20. A single injection of 19 kda carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 (PyMSP1(19)) formulated with Montanide ISA and CpG ODN induces protective immune response in mice.
Hirunpetcharat C; Mahakunkijcharoen Y; Jeamwattanalert P; Kittigul L; Mahannop P; Pichyangkul S
Asian Pac J Allergy Immunol; 2011 Sep; 29(3):252-9. PubMed ID: 22053595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
